Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models

LJ Crawford, ET Chan, M Aujay, TL Holyoake, JV Melo, HG Jorgensen, S Suresh, B Walker, AE Irvine

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)
185 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models'. Together they form a unique fingerprint.

Medicine & Life Sciences